The price of a drug should be based on its therapeutic benefits – not just what the market will bear

The U.S. pharmaceutical industry has innovated in response to the pandemic, providing not only vaccines but also therapies to treat people with COVID-19. But an outdated law designed to spur development of lifesaving drugs risks making new treatments—for COVID-19 as well as other diseases—unaffordable for many Americans. Many pharmaceutical companies rely on the Orphan Drug Act, which President Ronald Reagan […]

Read more